Freedom of Information responses from the MHRA - week commencing 8 February 2021
Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 8 February 2021
- From:
- Medicines and Healthcare products Regulatory Agency
- Published
- 24 March 2021
Documents
Freedom of Information request on batch testing of isotretinoin (FOI 21-024) part 1
PDF, 5.58 MB, 50 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Freedom of Information request on batch testing of isotretinoin (FOI 21-024) part 2
PDF, 13.9 MB, 91 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Freedom of Information request on BUFYL 1.25mg/ml and 2microgram/ml Solution for Infusion (FOI 21-037) part 1
PDF, 14.5 MB, 36 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Freedom of Information request on BUFYL 1.25mg/ml and 2microgram/ml Solution for Infusion (FOI 21-037) part 2
PDF, 3.52 MB, 50 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Freedom of Information request on Lamisil 1% Spray – Information and Clinical Studies (FOI 21-051)
PDF, 4.33 MB, 14 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
See the MHRA FOI disclosure log.
See all FOI responses from the MHRA for 2021.